Jonathan P Piccini
Duke Clinical Research Organization · Duke University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jonathan P Piccini as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:39 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05130268 · Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial FibrillationAmerican Heart Association · completed · Atrial Fibrillation · principal investigator
- N/ANCT00498524 · Risk of Life-threatening Heart Rhythm Disturbances in SiblingsDuke University · completed · Defibrillators, Implantable, Myocardial Infarction, Tachycardias, Ventricular · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Neurocognition and Greater Maintenance of Sinus Rhythm in AF (NOGGIN AF)R01AG074185 · NIA · DUKE UNIVERSITY · fiscal years 2021 to 2025 · $709,180 awarded in 2025Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:39 UTC. The ranking covers the 200 most relevant of 99 PubMed records, and a shared surname and initials can bring in a namesake. All 99 on PubMed
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.N Engl J Med · 20117,391 citationsRCR 248.5
- 1,223 citationsRCR 62.5
- 522 citationsRCR 26.4
- 459 citationsRCR 13.9
- 428 citationsRCR 13.7
- Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.J Am Coll Cardiol · 2016421 citationsRCR 18.0
- The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.Eur Heart J · 2015389 citationsRCR 15.0
- 313 citationsRCR 11.3
- Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.Eur Heart J · 2015301 citationsRCR 10.9
- Updated performance of the Micra transcatheter pacemaker in the real-world setting: A comparison to the investigational study and a transvenous historical control.Heart Rhythm · 2018297 citationsRCR 15.2